Integra LifeSciences Holdings Aktie
WKN DE: 897013 / ISIN: US4579852082
|
30.10.2025 12:46:27
|
Integra LifeSciences Q3 Adj. EPS Tops Estimates, But Revenues Miss
(RTTNews) - Medical technology company Integra LifeSciences Holdings Corp. (IART) reported Thursday a net loss for the third quarter of $5.40 million or $0.07 per share, narrower than $10.70 million or $0.14 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter was $0.54 per share, compared to $0.41 per share in the year-ago quarter.
Total revenues for the quarter grew 5.6 percent to $402.06 million from $380.83 million in the same quarter last year. Organic revenue grew 5.0 percent.
On average, ten analysts polled expected the company to report earnings of $0.43 per share on revenues of $414.31 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Integra LifeSciences Holdings Corp.mehr Nachrichten
Analysen zu Integra LifeSciences Holdings Corp.mehr Analysen
Aktien in diesem Artikel
| Integra LifeSciences Holdings Corp. | 9,75 | -2,01% |
|